PEOPLE - SELECT Therapeutics makes appointment:
This article was originally published in Clinica
The chairman of SELECT Therapeutics has announced the appointment of Andrew Muir as CEO and director. Dr Muir possesses over 30 years of management experience and is a member of the board of directors for several private technology companies. The vice-chairman of the board has been named as Thomas Reardon, who has been with the company since 1999. Steve Peltzman has resigned as CEO.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.